Furthermore, univariate analysis showed that gender (P = 0.026), lymph node metastasis (P < 0.001), clinical stage (P = 0.001) and PGM5 expression (P = 0.001) were significant predictors of overall survival in CRC. The gene discussed is PGM5; the disease is metastatic malignant neoplasm in the lymph nodes.